Enzo Biochem, Inc. (ENZ) Widens Q4 Loss to 69c/Share

Enzo Biochem, Inc. (NYSE: ENZ) reported Q4 EPS of ($0.69), versus ($0.11) reported last year. Revenue for the quarter came in at $26.4 million, versus $26.8 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman starts Talen at buy, sees PJM power tightness boosting earnings
• Pfizer reaffirms 2026 guidance after CFO transition news